Monoclonal antibodies against glycoprotein of Ebola sudan boniface virus

  • US Patent No. 9097713
  • Issued: August 04, 2015
  • Status: Active
Medical & Biotechnology

We disclose Ebola Sudan Boniface virus GP Monoclonal antibodies, epitopes recognized by these monoclonal antibodies, and the sequences of the variable regions of some of these antibodies. Also provided are mixtures of antibodies of the present invention, as well as methods of using individual antibodies or mixtures thereof for the detection, prevention, and/or therapeutic treatment of Ebola Sudan Boniface virus infections in vitro and in vivo.

Do you have questions or need more information on a specific technology? Let's talk.

Contact Us